Background/Aims: To evaluate the effects of the antioxidant N-acetylcysteine (NAC) on cardiac structure and function in rats with long-term ascending aortic stenosis (AS). Methods: Four months after inducing AS, Wistar rats were assigned into the groups Sham, AS, and AS treated with NAC (AS-NAC) and followed for eight weeks. Cardiac structure and function were evaluated by echocardiogram. Myocardial antioxidant enzymes activity was measured by spectrophotometry and malondialdehyde serum concentration by HPLC. Gene expression of NADPH oxidase subunits NOX2, NOX4, p22 phox, and p47 phox was assessed by real time RT-PCR and protein expression of MAPK proteins by Western blot. Statistical analyzes were performed with Goodman and ANOVA or Mann-Whitney. Results: NAC restored myocardial total glutathione (Sham 20.8±3.00; AS 12.6±2.92; AS-NAC 17.6±2.45 nmol/g tissue; p<0.05 AS vs Sham and AS-NAC). Malondialdehyde serum concentration was lower in AS-NAC and myocardial lipid hydroperoxide was higher in AS (Sham 199±48.1; AS 301±36.0; AS-NAC 181±41.3 nmol/g tissue). Glutathione peroxidase activity was lower in AS than Sham. Echocardiogram showed LV concentric hypertrophy with systolic and diastolic dysfunction before and after treatment; no differences were observed between AS-NAC and AS groups. NAC reduced p-ERK and p-JNK protein expression, attenuated myocardial fibrosis, and decreased the frequency of right ventricular hypertrophy. Conclusion: N-acetylcysteine restores myocardial total glutathione, reduces systemic and myocardial oxidative stress, improves MAPK signaling, and attenuates myocardial fibrosis in aortic stenosis rats.
Introduction
The transition from compensated left ventricular (LV) hypertrophy to heart failure is a critical event in patients with long-term pressure overload conditions such as systemic arterial hypertension and aortic stenosis [1] . Although several mechanisms may be involved in the development of heart failure, its pathophysiology is not completely understood [2] [3] [4] .
Oxidative stress is often observed and considered to play an important role on pathological cardiac remodeling and the transition to cardiac failure [5, 6] . Despite the importance of oxidative stress in inducing myocardial damage, antioxidant therapy is still a matter of controversy in heart failure treatment [7, 8] . Glutathione (L-γ glutamyl-cysteinylglycine) is an endogenous tripeptide that plays a central role in cellular defense against oxidative stress [9] . It is synthesized and maintained at high concentrations in cells [10] . In heart failure, glutathione redox status changes and its total concentration decreases in myocardium [11, 12] . N-acetylcysteine (NAC) is a molecule with antioxidant properties; it possesses a sulfhydryl group which acts as a source of cysteine to glutathione synthesis. NAC administration has been shown to restore total glutathione levels and reduce oxidative stress in infarcted rat hearts [11] . Furthermore, NAC attenuates cardiac and myocyte hypertrophy, interstitial fibrosis, LV dysfunction, and arrhythmogenic propensity in different experimental cardiac injury models [12] [13] [14] [15] . However, the effects of NAC during the transition from compensated LV hypertrophy to clinical heart failure have not been established.
Ascending aortic stenosis in rats is a useful model to study chronic pressure overloadinduced cardiac remodeling. In this model, three-four week-old rats are subjected to a clip being placed around the ascending aorta. After clip placement, aorta diameter is preserved; as rats grow, stenosis and LV hypertrophy progressively develop. In this model, ventricular dysfunction and clinical heart failure occur slowly, similarly to what is seen in human chronic pressure overload [16, 17] . In this study, we evaluated the effects of NAC administration on systemic and myocardial oxidative stress and cardiac remodeling in rats during transition from compensated LV hypertrophy to heart failure.
Materials and Methods

Experimental groups
Male Wistar rats weighing 90-100 g were purchased from the Central Animal House, Botucatu Medical School, Sao Paulo State University, UNESP, Brazil. All experiments and procedures were approved by the Animal Experimentation Ethics Committee of Botucatu Medical School, which follows the guidelines established by the Brazilian College for Animal Experimentation (protocol number 1071/2014).
Rats were anaesthetized with a mixture of ketamine hydrochloride (50 mg/kg, i.m.) and xylazine hydrochloride (10 mg/kg, i.m.) and aortic stenosis (AS) was induced by placing a 0.6 mm stainless-steel clip on the ascending aorta via a median thoracic incision according to a previously described method [16] . During surgery, the rats were manually ventilated using positive pressure and given 1 mL of warm saline solution intraperitoneally. Sham operated rats were used as controls. All animals were housed in a temperature controlled room at 23 °C and kept on a 12-hour light/dark cycle. Food and water were supplied ad libitum.
Four months after surgery, rats were subjected to transthoracic echocardiogram to evaluate the degree of cardiac injury, and assigned to three groups: control (Sham, n=16), AS (n=22), and AS treated with N-acetylcysteine (AS-NAC, n=15). N-acetylcysteine (Sigma, St. Louis, MO, USA) was added to chow at a dosage of 120 mg/kg/day for eight weeks. At the end of the experimental period, rats were subjected to transthoracic echocardiogram and euthanized the next day. During euthanasia, we determined the presence or absence of clinical and pathological heart failure features. The clinical finding suggestive of heart failure was tachypnea/labored respiration. Pathologic assessment of heart failure included pleuropericardial effusion, atrial thrombi, ascites, hepatic congestion, pulmonary congestion (lung weight/body weight ratio higher than 2 standard deviations above Sham group mean), and right ventricular hypertrophy (right ventricle weight/body weight ratio higher than 0.8 mg/g) [18, 19] .
Echocardiography
Cardiac structures and left ventricular (LV) function were evaluated by transthoracic echocardiogram and tissue Doppler imaging (TDI) using a commercially available echocardiograph (General Electric Medical Systems, Vivid S6 model, Tirat Carmel, Israel) equipped with a 5-11.5 MHz multifrequency transducer as previously described [20] [21] [22] . After anesthesia with ketamine hydrochloride (50 mg/kg) and xylazine hydrochloride (1 mg/kg) intramuscularly, the rats were placed in left lateral decubitus. A two dimensional parasternal short-axis view of the LV was obtained at the level of the papillary muscles. M-mode tracings were obtained from short-axis views of the LV at or just below the tip of the mitral-valve leaflets and at the level of the aortic valve and left atrium. M-mode images of the LV were printed on a black-and-white thermal printer (Sony UP-890MD) at a sweep speed of 200 mm/s. All structures were manually measured by the same observer (KO). Values obtained were the mean of at least five cardiac cycles on M-mode tracings. The following structural variables were measured: left atrium diameter (LA), LV diastolic and systolic diameters (LVDD and LVSD, respectively), LV diastolic (D) and systolic (S) posterior wall thickness (PWT) and septal wall thickness (SWT), and aortic diameter. Left ventricular mass (LVM) was calculated using the formula [(LVDD + DPWT + DSWT) 3 − LVDD 3 ] × 1.04. LV relative wall thickness (RWT) was calculated by the formula 2 × DPWT/LVDD. LV function was assessed by the following parameters: endocardial fractional shortening (EFS), midwall fractional shortening (MFS), ejection fraction (EF), posterior wall shortening velocity (PWSV), early and late diastolic mitral inflow velocities (E and A waves), E/A ratio, E-wave deceleration time (EDT), and isovolumetric relaxation time (IVRT). A joint assessment of diastolic and systolic LV function was performed using the myocardial performance index (Tei index). The study was complemented with evaluation by TDI of systolic (S'), early diastolic (E'), and late diastolic (A') velocity of the mitral annulus (arithmetic average of the lateral and septal walls) and E/E' ratio [23] .
Collection of left ventricle and other tissues
One day after final echocardiogram, the rats were weighed and anesthetized with intraperitoneal sodium pentobarbital (50 mg/kg) and euthanized. After blood collection, hearts (not arrested in diastole) were removed by thoracotomy. Atria and ventricles were dissected, weighed separately, frozen in liquid nitrogen, and stored at −80 °C. Lung weight was used to assess the degree of pulmonary congestion [24] .
Morphologic study
Frozen LV samples were transferred to a cryostat and cooled to -20 °C. Serial transverse 8 μm thick sections were stained with hematoxylin and eosin. At least 50 cardiomyocyte diameters were measured from each LV as the shortest distance between borders drawn across the nucleus [25] . Other slides were stained with Sirius red F3BA and used to quantify interstitial collagen fraction [26] . On average, 20 microscopic fields were analyzed with a 40X lens. Perivascular collagen was excluded from this analysis. Measurements were taking using a microscope (Leica DM LS; Nussloch, Germany) attached to a computerized imaging analysis system (Media Cybernetics, Silver Spring, MD, USA) [27] .
Oxidative stress evaluation Myocardial glutathione concentration
Reduced glutathione was determined using a kinetic method in media consisting of 100 mM phosphate buffer pH 7.4 containing 5 mM EDTA, 2 mM 5.5'-dithiobis-(2-nitrobenzoic) acid (DTNB), 0.2 mM NADPH 2 and 2 U of glutathione reductase according to a previously describe method [28] . Total glutathione was measured in the presence of 0.1 M Tris-HCl buffer, pH 8.0 with 0.5 mM EDTA, 0.6 mM DTNB and 0.1 U glutathione reductase [28] .
Antioxidant enzymes activity and lipid hydroperoxide concentration
Left ventricular samples (∼200 mg) were homogenized in 5 mL of cold 0.1 M phosphate buffer, pH 7.0. Tissue homogenates were prepared in a motor-driven Teflon glass Potter-Elvehjem tissue homogenizer. The homogenate was centrifuged at 10, 000 g, for 15 min at 4 °C, and the supernatant was assayed for total protein, lipid hydroperoxide [29] , and glutathione peroxidase (GSH-Px, E.C.1.11.1.9), catalase (E.C.1.11.1.6.), and superoxide dismutase (SOD, E.C.1.15.1.1.) activities by spectrophotometry [30] . Enzyme activities were analyzed at 25 °C using a microplate reader (Quant-MQX 200) with KCjunior software for computer system control (Bio-Tech Instruments, Winooski, Vermont, USA). Spectrophotometric determinations were performed in a Pharmacia Biotech spectrophotometer with temperature controlled cuvette chamber (UV/ visible Ultrospec 5000 with Swift II applications software for computer system control, Cambridge, UK). All reagents were purchased from Sigma-Aldrich (St. Louis, MO, USA).
Malondialdehyde serum concentration
Systemic lipid peroxidation was assessed by measuring malondialdehyde (MDA) serum concentration by high performance liquid chromatography (HPLC), as previously reported [31] . Briefly, 100 μL of serum were treated with 700 μL of 1% orthophosphoric acid and vortex-mixed for 10 s for protein precipitation. Then, 200 μL of thiobarbituric acid (TBA) were added. The mixture was heated to 100 ºC for 60 min and cooled to -20 ºC for 10 min. Then, 200 μL of this reaction were added to a solution containing 200 μL of NaOH:methanol (1:12). The tubes were centrifuged for 3 min at 13, 000 g; 200 μL of the supernatant were taken for injection in the equipment. Analysis was performed on a Shimadzu HPLC using a C18 5 μm Gemini Phenomenex column, and an Rf-535 fluorescence detector, which was set to Ex 525 nm and EM 551 nm. The mobile phase consisted of a 60:40 (v/v) mixture of 10 mmol potassium dihydrogen phosphate (pH 6.8): methanol. MDA was quantified by a calibration curve, which was constructed every day for analysis [31] .
Real-Time Quantitative Reverse Transcription-Polymerase Chain Reaction (RT-PCR)
Gene expression of NADPH oxidase subunits (NOX2, NOX4, p22 phox, and p47 phox) and reference genes cyclophilin and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was analyzed by RT-PCR according to a previously described method [32] . Total RNA was extracted from LV myocardium with TRIzol Reagent (Invitrogen Life Technologies, Carlsbad, CA, USA) and treated with DNase I (Invitrogen Life Technologies). One microgram of RNA was reverse transcribed using High Capacity cDNA Reverse Transcription Kit, according to standard methods (Applied Biosystems, Foster City, CA, USA). Aliquots of cDNA were then submitted to real-time PCR reaction using a customized assay containing sense and antisense primers and Taqman (Applied Biosystems, Foster City, CA, USA) probes specific to each gene: NOX2 (Rn00576710 m1), NOX4 (Rn00585380 m1), p22 phox (Rn00577357 m1), and p47 phox (Rn00586945 m1). Amplification and analysis were performed using Step One Plus™ Real-Time PCR System (Applied Biosystems, Foster City, CA, USA). Expression data were normalized to reference gene expressions: cyclophilin (Rn00690933 m1) and GAPDH (Rn01775763 g1). Reactions were performed in triplicate and expression levels calculated using the CT comparative method (2 −ΔΔCT ).
Western blotting
Protein levels were analyzed by Western blotting as previously described [33, 34] using specific antibodies (Santa Cruz Biotechnology, Santa Cruz, CA, USA): total JNK1/2 (sc-137019), p-JNK (sc-6254), total p38-MAPK (sc-7972), p-p38-MAPK (sc-17852), total ERK 1 (sc-93), and p-ERK1/2 (sc-16982). Protein levels were normalized to GAPDH (6C5 sc-32233). Myocardial protein was extracted using RIPA buffer (containing proteases and phosphatases inhibitors); supernatant protein content was quantified by the Bradford method. Samples were separated on a polyacrylamide gel and then transferred to a nitrocellulose membrane. After blockade, membrane was incubated with the primary antibodies. The membrane was then washed with TBS and Tween 20 and incubated with secondary peroxidase-conjugated antibodies. Super Signal ® West Pico Chemiluminescent Substrate (Pierce Protein Research Products, Rockford, USA) was used to detect bound antibodies. The membrane was then stripped (Restore Western Blot Stripping Buffer, Pierce Protein Research Products, Rockford, USA) to remove previous antibody. After blockade, the membrane was incubated with anti-GAPDH antibody.
Statistical analysis
Data are expressed as mean ± standard deviation or median and percentiles. Comparisons between groups were performed by one-way ANOVA and Tukey test or Kruskal-Wallis and Dunn test. Frequency of heart failure features was assessed by the Goodman test. Significance level was set at 5%. 
Results
At the end of the experimental period, Sham group had 16 animals, AS 22, and AS-NAC had 15 rats. Before treatment, both aortic stenosis groups presented dilated left atrium and concentric LV hypertrophy with diastolic dysfunction and mild systolic dysfunction (Tables 1 and 2 ). Except for a lower systolic posterior wall thickness, AS-NAC did not differ from AS. At the end of the experiment, AS-NAC and AS preserved the same pattern of LV concentric hypertrophy and dysfunction. No differences were observed between AS-NAC and AS (Tables  3 and 4) .
Heart failure feature frequencies are presented in Table 5 . One rat from Sham had ascites. AS-NAC had a lower frequency of right ventricular hypertrophy than AS. Anatomical variables are shown in Table  6 . Final body weight did not differ between groups. Absolute and normalized LV, right ventricle, and atria weights were higher in AS and AS-NAC than Sham. Lung weight and lung weight-to-body weight ratio were higher in AS than Sham.
Total glutathione was lower in AS than Sham and AS-NAC and reduced glutathione was lower in both AS and AS-NAC (Fig.  1) . Systemic and myocardial markers of oxidative stress were reduced in AS-NAC. Malondialdehyde serum concentration was lower in AS-NAC than Sham and AS. Lipid hydroperoxide myocardial concentration was lower in AS-NAC and Sham than AS (Fig. 2) . Antioxidant enzyme activities are shown in Fig. 3 . Superoxide dismutase was lower in AS and AS-NAC than Sham and glutathione peroxidase was lower in AS than Sham. Catalase activity did not differ between groups. NADPH oxidase subunit gene expression did not differ between groups (Table 7) .
Myocyte diameter was higher in AS than Sham and did not differ between AS-NAC and both AS and Sham groups (Table  8) . Interstitial collagen fraction was higher in AS than Sham and AS-NAC (Table 8) . Myocardial MAPK proteins expression is shown in Table 9 . Phosphorylated-ERK/ total ERK ratio was higher in AS than Sham and AS-NAC and p-JNK/GAPDH ratio was lower in AS-NAC than AS. 
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Discussion
In this study, the effects of NAC were evaluated in aortic stenosis rats during the transition from LV compensated hypertrophy to overt heart failure.
Aortic stenosis in young rats has been often used to evaluate persistent pressure overload from early LV concentric hypertrophy through gradual LV dysfunction and decompensated heart failure [16] . After aortic stenosis induction, rats remain compensated for approximately 20 to 28 weeks [35] . They then begin to present clinical and pathological heart failure features and evolve to death within two to four weeks. In this study, after a chronic period of LV hypertrophy, rats were randomly distributed into different treatment groups. Cardiac structures and LV function were evaluated by transthoracic echocardiogram before and after NAC treatment. The presence of cardiac failure was demonstrated by the high frequency of heart failure features observed at euthanize in the AS group. Lung congestion and right ventricular hypertrophy have been often used to diagnose heart failure in post-mortem rats [36, 37] .
Before treatment, aortic stenosis rats had concentric LV hypertrophy characterized by an increase in LV mass, LV wall thicknesses, and relative wall thickness. Mild systolic dysfunction was characterized by reduced posterior wall shortening velocity, and diastolic dysfunction by increased E wave and E/TDI E' ratio, and reduced isovolumetric relaxation time (IVRT) and E wave deceleration time. At the end of the experiment, both AS and AS-NAC preserved the same pattern of cardiac remodeling. No differences between AS-NAC and AS groups were observed. Therefore, despite of the fact that AS-NAC had a lower frequency of right ventricular hypertrophy than AS, we failed to show beneficial effects of NAC on cardiac structure and LV function. NAC is a precursor to an important intracellular defense mechanism against oxidative damage. By providing cysteine to glutathione synthesis, NAC replenishes glutathione, which is usually depleted in several disease states [12] . The replenishment of glutathione in deficient cells plays a central role in the effects of NAC as an antioxidant agent [10] . In fact, NAC is probably ineffective in cells replete in glutathione [10] . This property is important for antioxidant agents because at appropriate concentrations, reactive oxygen species also have fundamental roles in cellular function [8, 38] .
In this study, we first analyzed myocardial glutathione status. Total glutathione was decreased in AS and normalized by NAC. However, reduced glutathione was decreased in AS and AS-NAC groups. Depleted cardiac total glutathione has been previously observed in both congestive heart failure patients and post-myocardial infarction rats, as has total glutathione repletion after NAC treatment in infarcted rats [11] . We next evaluated systemic and myocardial markers of oxidative stress and myocardial antioxidant enzyme activity. Myocardial oxidative stress, analyzed by lipid hydroperoxide concentration, was higher in AS and normalized by NAC. Interestingly, malondialdehyde serum concentration was decreased in AS-NAC compared to both Sham and AS groups. As total glutathione was replenished in AS-NAC, glutathione peroxidase activity was normalized and its ability to neutralize free radicals increased, resulting in reduced lipoperoxidation. Therefore, NAC administration restored myocardial total glutathione and glutathione peroxidase activity, and reduced myocardial and systemic oxidative stress markers.
The NADPH oxidase family, composed of enzymes whose main function is producing reactive oxygen species, is involved in the pathophysiology of several cardiovascular diseases [5, 6, 39] . To evaluate the potential role of NADPH oxidase on increased oxidative stress, we assessed gene expression of NOX2 and NOX4 -the main cardiac isoforms, p22 phox -the transmembrane protein, and p47 phox -the NOX2 cytosolic regulatory subunit, all which did not differ between groups. However, as we did not evaluate NADPH oxidase activity, we cannot discard the possible influence of NADPH oxidase on increased oxidative stress in the AS group. We have previously observed that NAC administration decreases NADPH oxidase activity and NOX4 and p22 phox gene expression in the soleus muscle of heart failure rats [40] . Experimental studies have shown that the mitogen-activated protein kinase (MAPK) signaling pathway is involved in myocardial response to oxidative stress in several conditions [41] [42] [43] . MAPK includes four subfamilies, three of which have been well characterized: extracellular regulated kinase (ERK 1/2), c-jun N-terminal kinase (JNK), and p38-MAPK. After oxidative stress increase, MAPK downstream signaling may lead to myocardial hypertrophy and fibrosis [6, 41, 42, 44] . We therefore evaluated MAPK protein expression and observed that p-ERK and p-JNK were lower in AS-NAC than AS. Probably as a consequence of the reduced oxidative stress and p-ERK and p-JNK signaling, myocardial fibrosis was attenuated by NAC treatment. As myocardial fibrosis is strongly related to poor outcome in cardiovascular diseases [2, 45] , this result is important for future clinical studies. [12, 14, 46] . Similarly, to our findings, NAC also reduced ERK and JNK phosphorylation [14, 46] . The antifibrotic effect of NAC was also observed in other models and organs [46] [47] [48] . Despite the well characterized actions of NAC on hypertrophic cardiomyopathy, its effects on aortic stenosis-induced cardiac remodeling have been poorly addressed. When administered before and after aortic stenosis in rats, NAC attenuated increase in LV weight and electrical remodeling [15] . On the other hand, NAC did not improve cardiac function in aortic stenosis mice [49] .
We have therefore shown for the first time that the antioxidant NAC restores myocardial total glutathione and reduces systemic and myocardial oxidative stress in aortic stenosis rats. Probably, as a consequence of this decreased oxidative stress, myocardial MAPK signaling was improved and interstitial fibrosis was attenuated. However, cardiac echocardiographic parameters were not changed and heart failure features were only marginally improved. NAC administration was probably initiated too late when rats had already presented advanced degrees of structural cardiac alterations, thus preventing a reverse remodeling process. Our results therefore allow us to propose the hypothesis that early administration of NAC may be a useful treatment for preventing pathological cardiac remodeling and LV dysfunction during persistent LV pressure overload. A limitation of this study is that as we have not evaluated aorta blood pressure, differences in blood pressure levels derived from aortic stenosis may have influenced cardiac variables. 
